Biomarkers in cardiovascular diseases

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogene...

Full description

Saved in:
Bibliographic Details
Other Authors: Tousoulis, Dimitris (Editor), Stefanadis, Christodoulos (Editor)
Format: Book
Language:English
Published: Boca Raton CRC Press/Taylor & Francis 2013
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-551953
005 202011915187
008 230807t20132013FLU a #001 deng D
020 # # |a 9781466587144  |q hardback 
020 # # |a 1466587148  |q hardback 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a WG 141 
090 0 0 |a WG141  |b B6158 2013 
245 0 0 |a Biomarkers in cardiovascular diseases  |c editors, Dimitris Tousoulis, Christodoulos Stefanadis 
264 # 1 |a Boca Raton  |b CRC Press/Taylor & Francis  |c 2013 
300 # # |a viii, 442 pages  |b illustrations  |c 24 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book 
650 1 2 |a Cardiovascular Diseases  |x diagnosis 
650 2 2 |a Cardiovascular Disease  |x prevention & control 
650 2 2 |a Biomarkers 
650 2 2 |a Risk Factors 
700 1 # |a Tousoulis, Dimitris  |e editor 
700 1 # |a Stefanadis, Christodoulos  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=551953 
998 # # |a 00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2||